Copyright
©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 111031
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.111031
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.111031
Table 1 Overall recipient and donor characteristics, n (%)
| Mean | SD | Median | Interquartile range | Frequency | |
| Recipient age | 47.3 | 13.7 | 48 | 19 | |
| Recipient HTN | 4 (2.7) | ||||
| Recipient atheroma | 12 (8.1) | ||||
| Recipient DM | 21 (14.1) | ||||
| Recipient BMI (kg/m2) | 27.1 | 2.95 | 27 | 4 | |
| Donor age | 47.7 | 12.3 | 48 | 19 | |
| Donor HTN | 1 (0.7) | ||||
| Donor atheroma | 2 (1.3) | ||||
| Donor DM | 9 (6) | ||||
| Donor BMI (kg/m2) | 27.7 | 4.57 | 27 | 4.57 | |
| Donor baseline estimated glomerular filtration rate | 90 | 0 |
Table 2 Perioperative characteristics of living donor kidney transplantation. mean cold ischaemic time (from time of kidney perfused with hypothermic perfusion solution to time out of ice), n (%)
| Maintenance immunosuppression | |
| Tacrolimus | 78 (53) |
| Tacrolimus + mycophenolate | 32 (21.4) |
| Tacrolimus + prednisolone + mycophenolate | 25 (16.8) |
| Tacrolimus + prednisolone | 12 (8.1) |
| Mismatch category (National Health Service Blood and Transplant) | |
| 1 | 17 (11.4) |
| 2 | 18 (12.1) |
| 3 | 67 (45) |
| 4 | 47 (31.5) |
| Cold ischaemia time (minutes) (mean ± SD) | 251 ± 104 |
| Vascular anatomy | |
| Single | 118 (79.2) |
| Multiple | 24 (16.1) |
| Reconstruction | 7 (4.7) |
| Modality of donor nephrectomy | |
| Mini open | 24 (16.1) |
| Hand-assisted retroperitoneoscopic | 42 (28.1) |
| Laparoscopic (including, hand-assisted) | 83 (55.7) |
Table 3 Overall recipient outcomes, n (%)
| Classification | Frequency |
| Length of stay | 7 (2) |
| Delayed graft function | 1 (0.67) |
| Perioperative bleeding | 7 (5.6) |
| Surgical site infection | 6 (4) |
| Overall incisional hernia | 11 (7.4) |
| Death with a functioning graft | 3 (2) |
| Return to dialysis | 9 (6) |
| Time to return to dialysis | 43.1 ± 12.1 |
| 1-year recipient survival | 99.3 |
| 3-year recipient survival | 96.4 |
| 5-year recipient survival | 94.6 |
| 1-year graft survival | 99.3 |
| 3-year graft survival | 97.2 |
| 5-year graft survival | 90.4 |
| 1-year recipient eGFR | 59.2 ± 16.3 |
| 3-year recipient eGFR | 54.6 ± 19.9 |
| 5-year recipient eGFR | 52.1 ± 22.5 |
| 5-year rejection | 19 (17) |
| 1-year donor eGFR | 67 (21.5) |
| 3-year donor eGFR | 68 (21) |
| 5-year donor eGFR | 70 (21) |
Table 4 Donor and recipient outcomes for subgroup analysis post living donor kidney transplantation, n (%)
| Group 1 | Group 2 | Group 3 | Group 4 | P value | |
| Delayed graft function | 0 | 1 | 0 | 0 | 0.398 |
| Perioperative bleeding | 2 | 2 | 1 | 2 | 0.615 |
| Surgical site infection | 3 | 1 | 1 | 1 | 0.941 |
| Incisional hernia | 0 | 2 | 3 | 2 | 0.227 |
| 1-year recipient survival | 100 | 100 | 97.5 | 100 | 0.433 |
| 1-year graft survival | 100 | 100 | 97.5 | 100 | 0.433 |
| 1-year recipient eGFR | 63.9 ± 15.3 | 55.9 ± 16.5 | 56.1 ± 14.6 | 58 ± 19.5 | 0.053 |
| 1-year donor eGFR | 67 (15.2) | 69 (14) | 67.6 (15.7) | 69.8 (14.2) | 0.834 |
| 3-year recipient survival | 98.1 | 97 | 97.4 | 89.5 | 0.451 |
| 3-year graft survival | 98.1 | 97 | 90 | 90.9 | 0.383 |
| 3-year recipient eGFR | 60 ± 19.3 | 52.3 ± 20.2 | 52 ± 16.7 | 51 ± 22.6 | 0.136 |
| 3-year donor eGFR | 71.2 (15) | 71.8 (15) | 70 (14.7) | 67.6 (15.1) | 0.801 |
| 5-year recipient survival | 97 | 92.8 | 85.3 | 82.4 | 0.170 |
| 5-year graft survival | 97 | 96 | 86.7 | 82.3 | 0.143 |
| 5-year recipient eGFR | 57.8 ± 21.6 | 51.7 ± 21.5 | 50.4 ± 22.3 | 45 ± 25.5 | 0.270 |
| 5-year rejection | 9 (26.5) | 3 (10.7) | 6 (18.2) | 1 (5.9) | 0.247 |
| 5-year donor eGFR | 70 (17.2) | 71.7 (14.3) | 72 (16) | 72 (12) | 0.568 |
Table 5 Linear regression analysis model for 5-year graft function
| Predictor | β | SE | P value |
| 5-year patient survival | 24.61 | 17.96 | 0.174 |
| Return to dialysis | -41.37 | 6.44 | 0.001 |
| Rejection | -14.31 | 4.94 | 0.005 |
| Subgroup comparisons | |||
| 1 and 2 | -6.30 | 4.77 | 0.189 |
| 1-3 | -4.25 | 4.57 | 0.354 |
| 1-4 | -11.80 | 5.58 | 0.037 |
| Intercept | 38.25 | 18.23 | 0.038 |
- Citation: Anastasopoulos NA, Charif R, Loucaidou M, Herbert PE, Muthusamy ASRE, Dor FJMF, Papalois VE. Outcomes of living donor kidney transplantation from extended criteria donors to extended criteria recipients: A retrospective cohort study. World J Transplant 2025; 15(4): 111031
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/111031.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.111031
